Shree Ganesh Remedies Quarterly Results for Trading Insights

SGRL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹5 Cr
QSept 2025
Quarterly Results

Shree Ganesh Remedies Quarterly Results Key Highlights

  • Revenue of ₹31 Cr in Sept 2025 (+14.8% vs Mar 2025, -6.1% vs Sept 2024)
  • Net Profit of ₹5 Cr in Sept 2025 (-28.6% vs Mar 2025, -16.7% vs Sept 2024)
  • EBITDA of ₹10 Cr in Sept 2025 (-16.7% vs Mar 2025)
  • Operating Margin of 32.0% in Sept 2025 (-8.0pp vs Mar 2025)
  • Earnings Per Share of ₹3.86 in Sept 2025 (-24.8% vs Mar 2025)

Shree Ganesh Remedies Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 31 27 25 33 39 14.8% -6.1%
Net Profit (₹ Cr) 5 7 4 6 13 - -
EBITDA (₹ Cr) 10 12 8 12 18 - -
EPS (₹) 3.86 5.13 2.68 4.97 10.01 - -
Operating Margin (%) 32.0% 40.0% 30.0% 35.0% 45.0% - -

Shree Ganesh Remedies Share Price Trend Around Quarterly Results

Visualize Shree Ganesh Remedies's 1-year price movement across quarterly results — ideal for logging trades in Shree Ganesh Remedies share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin 16.1%
EBITDA Margin 32.3%
Operating Margin 32.0%
ROE (Annual) 13.8%

Balance Sheet Highlights

Total Assets ₹192 Cr
Total Equity ₹145 Cr
Current Assets ₹78 Cr
Current Liabilities ₹31 Cr

Cash Flow Analysis

Operating Cash Flow ₹31 Cr
Investing Cash Flow ₹-36 Cr
Financing Cash Flow ₹-1 Cr
Net Cash Flow ₹-6 Cr

Current Market Data

Current Price ₹447.90
Exchange BSE
Last Updated Jan 06, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Shree Ganesh Remedies quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹422,330.94 Cr 1760.2 14,875 3,125 +10.8% - 21.0% 135.4
Divis Laboratories
Sept 2025
₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025
₹136,522.12 Cr 3936.8 3,219 591 +11.3% - 18.4% 224.4
Cipla
Sept 2025
₹121,238.47 Cr 1530.8 7,716 1,353 +12.0% - 17.5% 91.5
Dr Reddys Laborator…
Sept 2025
₹104,829.57 Cr 1256.2 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores